“ EVERYBODY COUNTS”

HIV/AIDS PRESENTATION
HINTS:
1. Background of HIV/AIDS (various hypothesis
that were developed concerning HIV/AIDS)
2. Problem statement about HIV/AIDS (why we
have to know various studies on HIV/AIDS)
3. Severity of the problem (globally and regionally)
4. Goals of WHO and MoH (Ministry of Health)
5. Conclusion (recommendation on what to be
done)
GENERAL OVERVIEW ON HIV/AIDS
 AIDS is caused by a human immunodeficiency virus
(HIV), which was originated in non-human primates in
Central and West Africa.

 Two types of HIV exist:

 HIV-1 and HIV-2.
 HIV-1 is more virulent, is more easily transmitted and is the
cause of the vast majority of HIV infections globally.

 HIV-2 is less transmittable and is largely confined to West

Africa
 BACKGROUND OF HIV/AIDS
1959: Congolese man
 was discovered in a preserved blood sample from a man
from Leopoldville in the Belgian Congo.

1960: Congolese woman

 was discovered in a preserved lymph node biopsy sample

1969: Robert Rayford

 researchers detected "a virus closely related or identical to
HIV-1 in his preserved blood and tissues.
 BACKGROUND OF HIV/AIDS
1973: Ugandan children
 Antibodies to virus like that of HIV was detected

 Spread to the Western Hemisphere

HIV-1 is believed to have arrived in Haiti from central
Africa, possibly from the Democratic Republic of the
Congo around 1967.
 BACKGROUND OF HIV/AIDS
1981-1982: From GRID to AIDS
 the syndrome was initially termed "GRID", or gay-
related immune deficiency.

By August 1982,
 new CDC-coined name: Acquired Immune Deficiency
Syndrome (AIDS).
 IDENTIFICATION OF THE VIRUS
May 1983: LAV
 isolation a new retrovirus from lymphoid ganglions that they
believed was the cause of AIDS. The virus was later named
lymphadenopathy-associated virus (LAV)

May 1984: HTLV-III

Robert Gallo of the US confirmed the discovery of the virus, but
they renamed it human T lymphotropic virus type III (HTLV-
III).

August 1984: ARV

 Dr. Jay Levy's group at the University of California, San Francisco
isolated the AIDS virus in 1983 and named it the AIDS-
associated Retrovirus (ARV).
 IDENTIFICATION OF THE VIRUS
May 1986: the name HIV
 In May 1986, the International Committee on
Taxonomy of Viruses ruled that both names should be
dropped and a new name, HIV (Human
Immunodeficiency Virus), be used.
Françoise Barré-Sinoussi. Photograph ©
International AIDS Society (IAS)/Marcus
Rose/Workers' Photos, 2013
THEORIES/HYPOTHESIS DEVELOPED ON HIV/AIDS
 Canadian flight attendant theory
(Patient zero hypothesis)
A Canadian airline steward named Gaëtan Dugas was
incorrectly called "Patient Zero“

 Bushmeat hunting theory

 is the most accepted theory

 HIV transmitted from Chimpanzee to human

zoonotically
PROBLEM STATEMENT ABOUT HIV/AIDS
(why we have to know various studies on
HIV/AIDS)
 So as to sensitize the society by educating them on the
nature ,effects and preventive measures, also to protect
ourselves from HIV/AIDS by taking preventive
measures.
 To know the scope of HIV/AIDS till today so as to carry
out more research to find the curative and effective
treatment on HIV/AIDS
SEVERITY OF THE PROBLEM
 HIV SEVERITY REGIONALLY
(GLOBAL HEALTH OBSERVATORY DATA)
HIV/AIDS SEVERITY IN TANZANIA
- Latest statistics on the status of the AIDS epidemic
GLOBAL HIV STATISTICS
(DATA SOURCE:UNAIDS

People living with HIV accessing antiretroviral therapy

 As of June 2017, 20.9 million people living with HIV were accessing
antiretroviral therapy, up from 17.1 million in 2015 and 7.7 million in
2010.
 GOALS OF WHO
(WHO SIX OPERATIONAL OBJECTIVES)
 strategic use of ARVs for HIV treatment and prevention;
 eliminating HIV in children and expanding access to
paediatric treatment;
 an improved health sector response to HIV among key
populations;
 further innovation in HIV prevention, diagnosis, treatment
and care;
 strategic information for effective scale up; and
 stronger links between HIV and related health outcomes.
 TANZANIA MoH GOALS
 To intervene aimed at prevention and Treatment.
 To reduce HIV stigma among the public and health
professionals
 To improve on the quality and quantity of human
resources
 to improve ARV supply management;
 to integrate HIV care with other health services, such
as TB
 CONCLUSION
 More research should be conducted on finding the
curative measures and vaccines on HIV/AIDS where
the WHO ,MoH and NGO’s should keep on
supporting researchers

"There is always hope in life, because there is

always hope in science."
- Françoise Barré-Sinoussi March 7, 2009 interview
 REFERENCES:
 www.who.int/topics/millennium_development_goals/diseas
es/en/
 https://www.google.com/search?q=HIV+EMBLEM&client
 http://www.who.int/gho/hiv/en/
 https://www.verywell.com/the-history-of-hiv
 https://www.verywell.com/francoise-barre-sinoussi-co-
discoverer-of-hiv-48696
 tanzania hiv treatment guideline 2016 - Google Search
 Fact sheet - Latest statistics on the status of the AIDS
epidemic | UNAIDS
 https://www.verywell.com/hiv-aids-4014705
 http://www.who.int/hiv/data/en/
MESSAGE
WE HIGHLY APPRECIATE
YOUR ATTENTION

“EVERYBODY COUNTS”
Prepared by:
1.WAPALILA ABEDNEGO JOB (MD student, UDAMSA member)
2.KITOSI ONESMO(MD student, UDAMSA member)